chr18-23544952-C-CCCCG
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000271.5(NPC1):c.1947+7_1947+8insCGGG variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00131 in 1,425,682 control chromosomes in the GnomAD database, including 12 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00023 ( 2 hom., cov: 0)
Exomes 𝑓: 0.0014 ( 10 hom. )
Consequence
NPC1
NM_000271.5 splice_region, intron
NM_000271.5 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0320
Genes affected
NPC1 (HGNC:7897): (NPC intracellular cholesterol transporter 1) This gene encodes a large protein that resides in the limiting membrane of endosomes and lysosomes and mediates intracellular cholesterol trafficking via binding of cholesterol to its N-terminal domain. It is predicted to have a cytoplasmic C-terminus, 13 transmembrane domains, and 3 large loops in the lumen of the endosome - the last loop being at the N-terminus. This protein transports low-density lipoproteins to late endosomal/lysosomal compartments where they are hydrolized and released as free cholesterol. Defects in this gene cause Niemann-Pick type C disease, a rare autosomal recessive neurodegenerative disorder characterized by over accumulation of cholesterol and glycosphingolipids in late endosomal/lysosomal compartments.[provided by RefSeq, Aug 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 18-23544952-C-CCCCG is Benign according to our data. Variant chr18-23544952-C-CCCCG is described in ClinVar as [Likely_benign]. Clinvar id is 284646.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.00143 (1830/1281772) while in subpopulation AMR AF= 0.0145 (590/40720). AF 95% confidence interval is 0.0135. There are 10 homozygotes in gnomad4_exome. There are 864 alleles in male gnomad4_exome subpopulation. Median coverage is 25. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPC1 | NM_000271.5 | c.1947+7_1947+8insCGGG | splice_region_variant, intron_variant | ENST00000269228.10 | NP_000262.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPC1 | ENST00000269228.10 | c.1947+7_1947+8insCGGG | splice_region_variant, intron_variant | 1 | NM_000271.5 | ENSP00000269228.4 | ||||
NPC1 | ENST00000591051.1 | c.1023+7_1023+8insCGGG | splice_region_variant, intron_variant | 2 | ENSP00000467636.1 | |||||
NPC1 | ENST00000540608.5 | n.1861+7_1861+8insCGGG | splice_region_variant, intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000229 AC: 33AN: 143802Hom.: 2 Cov.: 0
GnomAD3 genomes
AF:
AC:
33
AN:
143802
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00230 AC: 553AN: 240878Hom.: 0 AF XY: 0.00197 AC XY: 258AN XY: 131214
GnomAD3 exomes
AF:
AC:
553
AN:
240878
Hom.:
AF XY:
AC XY:
258
AN XY:
131214
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00143 AC: 1830AN: 1281772Hom.: 10 Cov.: 25 AF XY: 0.00134 AC XY: 864AN XY: 644492
GnomAD4 exome
AF:
AC:
1830
AN:
1281772
Hom.:
Cov.:
25
AF XY:
AC XY:
864
AN XY:
644492
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000229 AC: 33AN: 143910Hom.: 2 Cov.: 0 AF XY: 0.000256 AC XY: 18AN XY: 70366
GnomAD4 genome
AF:
AC:
33
AN:
143910
Hom.:
Cov.:
0
AF XY:
AC XY:
18
AN XY:
70366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 11, 2015 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not provided Benign:2
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Niemann-Pick disease, type C1 Benign:2
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 27, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
NPC1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 15, 2023 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at